Feiyu Chen

The University of Texas MD Anderson Cancer Center

Also affiliated with Anhui University, Sun Yat-sen University, Fudan University, Liaoning University of Traditional Chinese Medicine, Wuhan No.1 Hospital, Zhongshan Hospital, Wuhan No. 7 Hospital, The First Affiliated Hospital, Sun Yat-sen University, Wuhan No.9 Hospital, Guangzhou Medical University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Immune checkpoint B7-H3 is a therapeutic vulnerability in prostate cancer harboring PTEN and TP53 deficiencies”.

Immune checkpoint B7-H3 is a therapeutic vulnerability in prostate cancer harboring PTEN and TP53 deficiencies

Science Translational Medicine(2023)10.1126/scitranslmed.adf6724

N/A

0DataRank · unranked

70 citations

Yin Wang, Yuehui Zhao, Justin J. Kim, Jiexi Li, Chenling Meng +9 more

CHD1 loss reprograms SREBP2-driven cholesterol synthesis to fuel androgen-responsive growth and castration resistance in SPOP-mutated prostate tumors

Nature Cancer(2025)10.1038/s43018-025-00952-z

N/A

0DataRank · unranked

11 citations

Jiexi Li, Yin Wang, Ximing Tang, Kevin Lin, Qidong Li +16 more

Histone methyltransferase ASH1L primes metastases and metabolic reprogramming of macrophages in the bone niche

Nature Communications(2025)10.1038/s41467-025-59381-2

N/A

0DataRank · unranked

11 citations

Kevin Lin, Wei Shi, Hongqi Teng, Xinhai Wan, Anna DeBruine +13 more